On #IndigenousPeoplesDay, we honor Native American & Alaskan Native communities—who face the highest #colorectalcancer mortality rates in the U.S. At Fight CRC, we're committed to confronting these disparities and fighting for more equity, awareness & time. 💙
September's clinical trial highlights are here! 🥳 This month: Antibody-drug conjugates (ADCs), ctDNA-guided strategies, and TP53-targeted approaches shaping the future of #ColorectalCancer care.
Hispanic/Latino patients are often diagnosed with #colorectalcancer at later stages, leading to worse outcomes. Screening saves lives—but barriers still exist. During #HispanicHeritageMonth, we're raising awareness and pushing for change. 💙
Michael is alive today because of FOLFOX, a chemo developed through federally funded #clinicaltrials. Now NIH's forward funding policy means fewer new grants and fewer breakthroughs.
Research saves lives—join the fight for more #colorectalcancer funding: fightcrc.org/takeaction 💙
We're proud to have Fight CRC's Hope Coordinator and stage I #CRC survivor, Paula Chambers Raney, speaking at the @theaacr.bsky.social conference today!💙 She highlighted why inclusive data collection across the cancer continuum is critical to driving progress for every community impacted by cancer.
Help us get life-changing resources into the hands of those who need them most. Become a #ResourceChampion & receive free resource boxes 2x a year to share with patients, caregivers, & providers in your area.
Have you had #biomarker testing? Do you know what it is—or what your results mean for treatment? If you answered no to any of these, it's time to join Biomarker School in our Community of Champions!
Research gave Bill more time and hope. But right now, the National Institute of Health is funding fewer cancer grants, and a proposed budget cut could slash research by 40%.
Only 3 days left to take part in our Local Drop-Off Challenge! 💙 Hand deliver a letter to your lawmaker and help get #CRC on their radar. Join the Community of Champions to get started—it's quick, impactful, and easy to do a... https://community.fightcrc.org/share/4RP9CPqgksLmkE7Z?utm_source=manual
The Division of Cancer Prevention and Control is at risk & so are the lives it helps save. Advocates are hand-delivering letters to lawmakers to show them what's at stake.
New #ClinicalTrials updates! Our Medical Advisory Board & RATS team curated August's top research highlights—covering BRAF, KRAS, and MSS biomarkers. These findings could shape treatment decisions and trial eligibility.
How would you feel about not being able to get the ostomy supplies that work best for your body?
That's what could happen to many ostomates if the Centers for Medicare & Medicaid Services (CMS) moves forward with a proposed change putting cost over personal medical needs.
